20% Prosol 1.18 g (Histidine LIQUID) 1.18 G

20% PROSOL 1.18 G is an intravenous solution containing histidine, used for medical applications. This liquid formulation is available in 500/1000/2000 mL packs, manufactured by Baxter Corporation in Canada.

Strength

1.18 G

Pack Size

500/1000/2000ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

20% PROSOL 1.18 G is primarily used in clinical settings for intravenous administration. Histidine, the active ingredient, is often utilized in medical procedures requiring amino acid supplementation. This solution may be part of treatments where histidine is indicated, such as certain metabolic or nutritional support therapies.

Side Effects

When administered intravenously, 20% PROSOL 1.18 G provides histidine directly into the bloodstream. This can help maintain amino acid levels in the body, supporting various physiological functions. The effects are typically monitored by healthcare professionals to ensure appropriate therapeutic outcomes.

Precautions & Warnings

As with any intravenous solution, 20% PROSOL 1.18 G should be handled with care. It is important to follow proper administration protocols to avoid complications. Patients should be monitored for any adverse reactions, and the solution should be stored according to the manufacturer's guidelines to maintain its integrity.

Avoid Interactions

Histidine may interact with certain medications or supplements. It is advisable to consult healthcare professionals before combining 20% PROSOL 1.18 G with other treatments. Additionally, patients should inform their healthcare providers about all medications they are taking to avoid potential interactions.

Frequently Asked Questions

20% PROSOL 1.18 G is used for intravenous administration of histidine, often in medical settings for amino acid supplementation.

This solution is administered intravenously, typically by healthcare professionals in a clinical setting.

The solution provides histidine directly into the bloodstream, supporting amino acid levels and various physiological functions.

Proper administration and monitoring are essential to avoid complications. Follow storage guidelines and consult healthcare professionals.

Histidine may interact with certain medications. Consult healthcare professionals before combining with other treatments.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.